Literature DB >> 28124208

MicroRNA-98 Attenuates Cell Migration and Invasion in Glioma by Directly Targeting Pre-B Cell Leukemia Homeobox 3.

Xiupeng Xu1, Zhongyuan Bao1, Yinlong Liu1, Jing Ji2, Ning Liu3.   

Abstract

Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults. The extraordinary invasion of human GBM into adjacent normal brain tissues contributes to treatment failure. However, the mechanisms that control this process remain poorly understood. Increasing evidence has demonstrated that microRNAs are strongly implicated in the migration and invasion of GBM. In this study, we found that microRNA-98 (miR-98) was markedly downregulated in human glioma tissues and cell lines. Functional experiments indicated that restored expression of miR-98 attenuated glioma cell invasion and migration, whereas depletion of miR-98 promoted glioma cell invasion and migration. Subsequent investigation showed that pre-B-cell leukemia homeobox 3 (PBX3), an important transcription factor that controls tumor invasion, was a direct and functional target of miR-98 in GBM cells. Consistently, an orthotopic mouse model also demonstrated the suppressive effects of miR-98 overexpression on tumor invasion and PBX3 expression. Silencing of PBX3 using small interfering RNA inhibited the migratory and invasive capacities of glioma cells, whereas reintroduction of PBX3 into glioma cells reversed the anti-invasive function of miR-98. Furthermore, depletion of PBX3 phenocopied the effects of miR-98 overexpression in vivo. Finally, quantitative real-time polymerase chain reaction results showed that miR-98 was negatively correlated with PBX3 expression in 24 glioma tissues. Thus, we propose that PBX3 modulation by miR-98 has an important role in regulating GBM invasion and may serve as therapeutic target for GBM.

Entities:  

Keywords:  Glioma; Invasion; Migration; PBX3; miR-98

Mesh:

Substances:

Year:  2017        PMID: 28124208     DOI: 10.1007/s10571-017-0466-4

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  46 in total

1.  miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.

Authors:  Yu Du; Yang Li; Hanxiao Lv; Songcheng Zhou; Zhen Sun; Min Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 2.  MicroRNA targeting as a therapeutic strategy against glioma.

Authors:  B Auffinger; B Thaci; A Ahmed; I Ulasov; M S Lesniak
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

3.  HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.

Authors:  Haitao Wang; Guanzhong Liu; Dan Shen; Huamao Ye; Jinming Huang; Li Jiao; Yinghao Sun
Journal:  Oncol Rep       Date:  2015-06-26       Impact factor: 3.906

4.  Tumor microenvironment complexity: emerging roles in cancer therapy.

Authors:  Melody A Swartz; Noriho Iida; Edward W Roberts; Sabina Sangaletti; Melissa H Wong; Fiona E Yull; Lisa M Coussens; Yves A DeClerck
Journal:  Cancer Res       Date:  2012-03-13       Impact factor: 12.701

5.  High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.

Authors:  Carla Hebert; Kathleen Norris; Mark A Scheper; Nikolaos Nikitakis; John J Sauk
Journal:  Mol Cancer       Date:  2007-01-14       Impact factor: 27.401

6.  HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways.

Authors:  Ran Duan; Lei Han; Qixue Wang; Jianwei Wei; Luyue Chen; Jianning Zhang; Chunsheng Kang; Lei Wang
Journal:  Oncotarget       Date:  2015-09-29

7.  Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98.

Authors:  Zigui Chen; Quan Cheng; Zhiming Ma; Haipeng Xi; Renjun Peng; Bing Jiang
Journal:  Biomed Res Int       Date:  2013-12-12       Impact factor: 3.411

8.  miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6.

Authors:  Fei Li; Xin-ji Li; Li Qiao; Fei Shi; Wen Liu; You Li; Yu-ping Dang; Wei-jie Gu; Xiao-gang Wang; Wei Liu
Journal:  Exp Mol Med       Date:  2014-10-03       Impact factor: 8.718

9.  MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.

Authors:  Sheng-Dong Huang; Yang Yuan; Chong-Wen Zhuang; Bai-Ling Li; De-Jun Gong; Shu-Gang Wang; Zhi-Yong Zeng; He-Zhong Cheng
Journal:  Mol Cancer       Date:  2012-08-06       Impact factor: 27.401

10.  MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.

Authors:  Wuyuan Zhou; Benkui Zou; Lisheng Liu; Kai Cui; Jie Gao; Shuanghu Yuan; Ning Cong
Journal:  Oncotarget       Date:  2016-11-08
View more
  13 in total

1.  MiR-421 inhibits the malignant phenotype in glioma by directly targeting MEF2D.

Authors:  Liang Liu; Sitong Cui; Rui Zhang; Yan Shi; Liangsheng Luo
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

2.  Occurrence of Second Primary Malignancies in Patients With Primary Optic Nerve Gliomas: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Zain Hussain; Jawad Khan; Amir Saeed; Fatma Dihowm
Journal:  Cancer Diagn Progn       Date:  2021-11-03

3.  MicroRNA-936 induces cell cycle arrest and inhibits glioma cell proliferation by targeting CKS1.

Authors:  Dong Wang; Tongle Zhi; Xiupeng Xu; Zhongyuan Bao; Liang Fan; Zheng Li; Jing Ji; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

4.  MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5.

Authors:  Xiupeng Xu; Ning Cai; Tongle Zhi; Zhongyuan Bao; Dong Wang; Yinlong Liu; Kuan Jiang; Liang Fan; Jing Ji; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

5.  Silencing Pre-B-cell leukemia homeobox 3 decreases the proliferation of human glioma cells in vitro and in vivo.

Authors:  Xiupeng Xu; Ning Cai; Zhongyuan Bao; Yongping You; Jing Ji; Ning Liu
Journal:  J Neurooncol       Date:  2017-08-30       Impact factor: 4.130

6.  miR-720 is a key regulator of glioma migration and invasion by controlling TARSL2 expression.

Authors:  Yinlong Liu; Kuan Jiang; Tongle Zhi; Xiupeng Xu
Journal:  Hum Cell       Date:  2021-05-23       Impact factor: 4.174

Review 7.  Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer.

Authors:  Evgeny Chirshev; Kerby C Oberg; Yevgeniya J Ioffe; Juli J Unternaehrer
Journal:  Clin Transl Med       Date:  2019-08-28

8.  Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.

Authors:  Naibing Gu; Xinlai Wang; Zhengli Di; Jing Xiong; Yue Ma; Yu'e Yan; Yihua Qian; Quanzeng Zhang; Jia Yu
Journal:  Aging (Albany NY)       Date:  2019-11-26       Impact factor: 5.682

9.  LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.

Authors:  Xiaoliu Du; Yiming Tu; Shuang Liu; Pengzhan Zhao; Zhongyuan Bao; Chong Li; Jinhao Li; Minhong Pan; Jing Ji
Journal:  J Cell Mol Med       Date:  2019-12-19       Impact factor: 5.310

10.  PBX3/MEK/ERK1/2/LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion.

Authors:  Xiupeng Xu; Zhongyuan Bao; Yinlong Liu; Kuan Jiang; Tongle Zhi; Dong Wang; Liang Fan; Ning Liu; Jing Ji
Journal:  J Exp Clin Cancer Res       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.